Updated:
Milemark Capital
Milemark Capital is a private equity based in Cambridge, founded 2023; the Altss profile covers its classification, headquarters, registration, AUM band, and...
Milemark Capital
Smart access to Applied-AI. We invest in early stage AI startups from diverse teams, born of innovation hubs
General information
Firm type
Private Equity
Year founded
2023
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Cambridge
Corporate office
Cambridge, MA, United States
Principals
Sebastian Barriga
Founding Partner
Adela Jamal
Founding Partner
Sinan Aral
Founding Partner
Michael Lipton
Founding Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Milemark Capital?
The four founding partners — Sebastian Barriga, Adela Jamal, Sinan Aral, and Michael Lipton — appear to make investment decisions collectively. The firm does not list a separate investment committee or junior investment staff. Aral provides the core AI expertise as an MIT professor, while Barriga brings institutional private equity experience from Carlyle and Lipton offers serial entrepreneurship and go-to-market skills.
How does Milemark Capital source proprietary deal flow?
Milemark's sourcing relies on deep institutional ties to MIT and Harvard. Aral is a chaired professor at MIT; the firm states its team is embedded in the square mile between the two universities. The partners serve as mentors for on-campus entrepreneurship programs and attend exclusive startup events on and around the campuses. This academic adjacency gives Milemark access to companies before they circulate widely to other venture firms.
Does Milemark Capital participate in fund commitments or only direct deals?
Based on the firm's public disclosures, Milemark invests directly into early-stage companies. There is no indication the firm makes commitments to external venture funds as a limited partner. Sinan Aral separately co-founded Manifest Capital, a Series-A venture fund, but Milemark's own portfolio is built from direct equity positions alongside board or advisory roles.
What investment stages does Milemark Capital typically target?
Milemark focuses on early-stage companies, typically at the seed or pre-seed stage. The portfolio includes companies still in stealth mode and academic spinouts that have not yet raised institutional venture rounds. The emphasis is on applied-AI startups that can demonstrate proprietary data or model advantages even at formation.
Which sectors does Milemark Capital explicitly avoid?
Milemark does not publish a negative sector list. Its stated thesis is sector-agnostic within applied AI, favoring opportunities where AI provides high leverage. Observed portfolio concentration in drug discovery, climate sensing, and enterprise automation suggests a de facto preference for deep-tech and science-heavy verticals, but no sector is formally excluded.
Where does the underlying capital come from?
Milemark has not publicly disclosed the source of its investment capital. The four founding partners bring varied professional backgrounds — private equity, investment banking, technology operations, and academia — but no single family wealth origin or anchor LP has been identified. The firm operates as an independent early-stage investment manager.
Does Milemark Capital maintain philanthropic structures, and how are they separated?
There is no public information about a philanthropic foundation tied to Milemark Capital. While the firm emphasizes diversity and inclusion in its investment thesis, this is executed through direct portfolio decisions and the composition of its partnership rather than through a separate philanthropic vehicle.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: